AI Makes Retinal Imaging 100 Times Faster, Compared to Manual Method
https://reachmd.com/news/ai-makes-retinal-imaging-100-times-faster-compared-to-manual-method/2462679/
Credit: Unsplash/CC0 Public Domain Researchers at the National Institutes of Health have applied artificial intelligence (AI) to a technique that produces high-resolution images of cells in the eye. T…
Brush Biopsy Enables Early Detection of Oral Cancer Without Surgery
https://reachmd.com/news/brush-biopsy-enables-early-detection-of-oral-cancer-without-surgery/2456905/
A new test invented by University of Illinois Chicago researchers allows dentists to screen for the most common form of oral cancer with a simple and familiar tool: the brush. The diagnostic kit, created and patented by Guy Adami and Dr. Joel Schwartz of the UIC College of Dentistry, uses a sm…
Drinkable, Carbon Monoxide-Infused Foam Enhances Effectiveness of Experimental Cancer Therapy
https://reachmd.com/news/drinkable-carbon-monoxide-infused-foam-enhances-effectiveness-of-experimental-cancer-therapy/2456859/
Gas-entrapping foam infused with carbon monoxide enhances anti-cancer activity of autophagy inhibitors, which may help improve therapies for many different cancers. Credit: University of Iowa Health Care …
Blood Test Distinguishes Neuroendocrine Subtype of Advanced Prostate Cancer
https://reachmd.com/news/blood-test-distinguishes-neuroendocrine-subtype-of-advanced-prostate-cancer/2456808/
Credit: Unsplash/CC0 Public Domain Like a criminal entering a witness protection program, cancer cells can shed their past and take on a new identity. Detecting such an identity switch is particularly challenging when metastatic castration-resistant prostate cancer (CRPC) advances from aden…
RemeGen to Present Telitacicept Phase III Clinical Trial Results for Rheumatoid Arthritis Patients in a Late-Breaking Abstract Oral Presentation Session at the American College of Rheumatology
https://reachmd.com/news/remegen-to-present-telitacicept-phase-iii-clinical-trial-results-for-rheumatoid-arthritis-patients-in-a-late-breaking-abstract-oral-presentation-session-at-the-american-college-of-rheumatology/2466992/
YANTAI, China, Nov. 15, 2023 /PRNewswire/ -- RemeGen Co., Ltd. ("RemeGen" or "the Company") (HKG: 9995, SHA: 688331), a commercial-stage biotechnology company, is invited to present telitacicept Phase III Clinical Trial Results for Rheumatoid Arthritis Patients in a Late-Breaking Abstract Oral Pre…
Hyperspectral Dark-Field Microscopy for Rapid and Accurate Identification of Cancerous Tissues
https://reachmd.com/news/hyperspectral-dark-field-microscopy-for-rapid-and-accurate-identification-of-cancerous-tissues/2463024/
Breast-conserving surgery (BCS), also called lumpectomy, involves the removal of a cancerous lump and some surrounding tissue. BCS is suitable for women with early-stage breast cancer or small lumps, as it preserves more of the breast compared to mastectomy. After BCS, it is crucial to ensure that …
Successful Murine Model of Dermatomyositis Reveals Underlying Immune System Involvement
https://reachmd.com/news/successful-murine-model-of-dermatomyositis-reveals-underlying-immune-system-involvement/2462697/
video: VI…
Vitamin D₂ May Help Preserve Honeymoon Phase of Type I Diabetes
https://reachmd.com/news/vitamin-d2-may-help-preserve-honeymoon-phase-of-type-i-diabetes/2462310/
by Bob Yirka , Medical Xpress …
New Tool Helps Decipher Gene Behaviour
https://reachmd.com/news/new-tool-helps-decipher-gene-behaviour/2457363/
Scientists have extensively researched the structure and sequence of genetic material and its interactions with proteins in the hope of understanding how our genetics and environment interact in diseases. This research has partly focused on ‘epigenetic marks’, which are chemical modifications to DN…
Priming, Shaping, and Polishing: In Search of a HIV Vaccine
https://reachmd.com/news/priming-shaping-and-polishing-in-search-of-a-hiv-vaccine/2456865/
Worldwide, an estimated, 40 million people live with HIV. Two-thirds of this group on the African continent. In 2022, more than 600,000 people died from HIV-related causes and more than 1.3 million were infected. There is no vaccine against the world's second most deadly infection, after TB. Than…